Increased Pro-Inflammatory Cytokines, C-Reactive Protein and Nerve Growth Factor Expressions in Serum of Patients with Interstitial Cystitis/Bladder Pain Syndrome

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Jiang, Yuan Hong ^a,b   Peng, Chung Hsin ^b,c   Liu, Hsin Tzu ^a,b   Kuo, Hann Chorng ^a,b  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

^c TAIPEI TZU CHI HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 8; NERVE GROWTH FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD SAMPLING; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INFLAMMATION; INFLAMMATORY DISEASE; INTERSTITIAL CYSTITIS; MALE; MAST CELL; PATHOGENESIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

ADULT; C-REACTIVE PROTEIN; CYSTITIS, INTERSTITIAL; CYTOKINES; FEMALE; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; NERVE GROWTH FACTOR;

EID: 84885763651     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076779     Document Type: Article

References (27)

1. Chancellor MB, Yoshimura N, (2004) Treatment of interstitial cystitis. Urology 63(3Suppl 1): 85-92.
2. Dupont MC, Spitsberegen JM, Kim KB, Tuttle JB, Steers WD, (2001) Histological and neurotrophic changes triggered by varying models of bladder inflammation. J Urol 166: 1111-8.
3. Bouchelouche K, Nordling J, (2003) Recent developments in the management of interstitial cystitis. Curr Opin Urol 13: 309-13.
4. Hanno PM, Sant GR (2001) Clinical highlights of the National Institute of Diabetes and Digestive and Kidney Diseases/Interstitial Cystitis Association scientific conference on interstitial cystitis. Urology (Suppl 6A): 2-6.
5. Lowe EM, Anand P, Terenghi G, Williams-Chestnut RE, Sinicropi DV, et al. (1997) Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis. Br J Urol 79: 572-7.
6. Liu HT, Tyagi P, Chancellor MB, Kuo HC, (2009) Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment. BJU Int 104: 1476-81.
7. Chung SD, Liu HT, Lin H, Kuo HC, (2011) Elevation of serum C-reactive protein in patients with OAB and IC/BPS implies chronic inflammation in the urinary bladder. Neurourol Urodyn 30: 417-20.
8. Sant GR, Kempuraj D, Marchand JE, Theoharides TC, (2007) The mast cell in interstitial cystitis: role in pathophysiology and pathogenesis. Urology 69: 34-40.
9. Tyagi P, Barclay D, Zamora R, Yoshimura N, Peters K, et al. (2010) Urine cytokines suggest an inflammatory response in the overactive bladder: a pilot study. Int Urol Nephrol 42: 629-35.
10. Wilkinson DR, Erickson AD, (2006) Urinary and serologic markers for interstitial cystitis: an update. Curr Urol Rep 7: 414-22.
11. Erickson DR, Belchis DA, Dabbs DJ, (1997) Inflammatory cell types and clinical features of interstitial cystitis. J Urol 158: 790-3.
12. Erickson DR, Tomaszewski JE, Kunselman AR, Bentley CM, Peters KM, et al. (2005) Do the National Institute of Diabetes and Digestive and Kidney Diseases cystoscopic criteria associate with other clinical and objective features of interstitial cystitis? J Urol 173: 93-7.
13. Lamale LM, Lutgendorf SK, Zimmerman MB, Kreder KJ, (2006) Interleukin-6, histamine, and methylhistamine as diagnostic markers for interstitial cystitis. Urology 68: 702-6.
14. Tseng-Rogenski S, Liebert M, (2009) Interleukin-8 is essential for normal urothelial cell survival. Am J Physiol Renal Physiol 297: F816-21.
15. Dodd LG, Tello J, (1998) Cytologic examination of urine from patients with interstitial cystitis. Acta Cytol 42: 923-7.
16. Van De Merwe JP, Arendsen HJ, (2000) Interstitial cystitis: a review of immunological aspects of the aetiology and pathogenesis, with a hypothesis. BJU Int 85: 995-9.
17. Bouchelouche K, Kristensen B, Nordling J, Horn T, Bouchelouche P, (2001) Increased urinary leukotriene E4 and eosinophil protein X excretion in patients with interstitial cystitis. J Urol 166: 2121-5.
18. Liu HT, Kuo HC, (2012) Increased urine and serum nerve growth factor levels in interstitial cystitis suggest chronic inflammation is involved in the pathogenesis of disease. PLos One 7: e44687.
19. Smaldone MC, Vodovotz Y, Tyagi V, Barday D, Philips BJ, et al. (2009) Multiplex analysis of urinary cytokine levels in rat model of cyclophosphamide-induced cystitis. Urology 73: 421-6.
20. Erickson DR, Tomaszewski JE, Kunselman AR, Stetter CM, Peters KM, et al. (2008) Urine markers do not predict biopsy findings or presence of bladder ulcers in interstitial cystitis/painful bladder syndrome. J Urol 179: 1850-6.
21. Bhangoo S, Ren D, Miller RJ, Henry KJ, Lineswala J, et al. (2007) Delayed functional expression of neuronal chemokine receptors following focal nerve demyelination in the rat: a mechanism for the development of chronic sensitization of peripheral nociceptors. Mol Pain 3: 38.
22. Tyagi P, Killinger K, Tyagi V, Nirmal J, Chancellor M, et al. (2012) Urinary chemokines as noninvasive predictors of ulcerative interstitial cystitis. J Urol 187: 2243-8.
23. March CJ, Mosley B, Larsen A, Cerretti DP, Braedt G, et al. (1985) Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs. Nature 315: 641-7.
24. Martins SM, Darlin DJ, Lad PM, Zimmern PE, (1994) Interleukin-1B: a clinically relevant urinary marker. J Urol 151: 1198-201.
25. Nielubowicz GR, Mobley HL, (2010) Host-pathogen interactions in urinary tract infection. Nat Rev Urol 7: 430-41.
26. Peters EM, Liezmann C, Spatz K, Daniltchenko M, Joachim R, et al. (2011) Nerve growth factor partially recovers inflamed skin from stress-induced worsening in allergic inflammation. J Invest Dermatol 131: 735-43.
27. Nickel JC, Tripp DA, Pontari M, Moldwin R, Mayer R, et al. (2010) Interstitial cystitis/painful bladder syndrome and associated medical conditions with an emphasis on irritable bowel syndrome, fibromyalgia and chronic fatigue syndrome. J Urol 184: 1358-63.